Home
Resources
Publications
Fraxin Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting the NF-κB and NLRP3 Signalling Pathways

Fraxin Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting the NF-κB and NLRP3 Signalling Pathways

Weifeng Li, Wenqi Li, Lulu Zang, Fang Liu, Qing Yao, Jinmeng Zhao, Wenbing Zhi, Xiaofeng Niu

Int Immunopharmacol. 2019 Feb;67:1-12.

PMID: 30530164

Abstract:

Fraxin, the effective component of the Chinese traditional medicine Cortex Fraxini, is reported to have anti-inflammatory effects. This study assessed the anti-inflammatory effect of fraxin on the lipopolysaccharide (LPS)-induced inflammatory response in A549 cells and the protective efficacy on LPS-induced acute lung injury (ALI) in mice. Fraxin reduced LPS-induced TNF-α, IL-6 and IL-1β production in A549 cells and alleviated the LPS-induced wet/dry (W/D) weight ratio and the effects observed via histopathological examination of the lung in vivo. Furthermore, fraxin reduced the protein concentrations in the broncho-alveolar lavage (BAL) fluid and cytokine production in the sera. Fraxin also clearly attenuated the oxidation index, including the activity of myeloperoxidase (MPO), malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione (GSH). Immunohistochemistry analysis showed that fraxin suppressed LPS-induced inflammatory damage. The expression of proteins involved in the NF-κB and NLRP3 inflammatory corpuscle signalling pathways was consistent between the lung tissues and cell samples. Overall, fraxin played a protective role in LPS-induced lung injury by inhibiting the NF-κB and NLRP3 signalling pathways.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP524301-A	Fraxin		524-30-1	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: